Clopidogrel hydrogen sulfate NEW
| Price | $30 | $40 | $50 |
| Package | 25mg | 50mg | 100mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2024-11-19 |
Product Details
| Product Name: Clopidogrel hydrogen sulfate | CAS No.: 120202-66-6 |
| Purity: 99.57% | Supply Ability: 10g |
| Release date: 2024/11/19 |
Product Introduction
Bioactivity
| Name | Clopidogrel hydrogen sulfate |
| Description | Clopidogrel hydrogen sulfate ((S)-(+)-Clopidogrel bisulfate) , a selective, high-affinity P2Y12 receptor antagonist, suppressess fibrinogen binding to platelets and platelet adhesion and aggregation. |
| In vitro | In a rat model of ulcer margins, daily administration of Clopidogrel (2 mg and 10 mg/kg) significantly reduced the proliferation of gastric epithelial cells induced by ulcers, as well as the expression of the EGF receptor and phosphorylated extracellular signal-regulated kinase. In rats with congestive heart failure, Clopidogrel enhanced the phosphorylation of AKT and eNOS, thereby improving vascular endothelial function and the bioavailability of nitric oxide. |
| In vivo | In RGM-1 cells, Clopidogrel (1 μM) inhibits the epidermal growth factor-induced activation of epidermal growth factor receptor, PERK expression, and cellular proliferation. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility Information | DMSO : 55 mg/mL (130.98 mM) |
| Keywords | Inhibitor | Antiplatelet | Clopidogrel hydrogen | Clopidogrel Bisulfate | P2Y Receptor | platelet | Clopidogrel hydrogen sulfate | CYP2C19 | CYPs | clot | antithrombotic | Clopidogrel hydrogen Sulfate | inhibit | aggregation | Cytochrome P450 | blood | CYP2B6 |
| Inhibitors Related | Tebuconazole | 1-Ethynylnaphthalene | Apigenin | Gemfibrozil | Fenofibrate | 1-Aminobenzotriazole | Uridine-5'-diphosphate disodium salt | Naringin | Naringenin | Tauroursodeoxycholate |
| Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | GPCR Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $30.00/25mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
| $9.90/1KG |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-10-31 | |
| $10.00/1kg |
VIP4Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-15 | |
| $0.00/1kg |
VIP1Y
|
Shaanxi TNJONE Pharmaceutical Co., Ltd
|
2024-04-26 | |
| $0.00/1Kg |
VIP1Y
|
airuikechemical co., ltd.
|
2024-03-29 | |
| $50.00/1kg |
VIP5Y
|
Hebei Yanxi Chemical Co., Ltd.
|
2023-09-21 | |
| $0.00/25KG |
VIP5Y
|
Hebei Mojin Biotechnology Co., Ltd
|
2023-08-28 | |
| $200.00/1kg |
Henan Bao Enluo International TradeCo.，LTD
|
2023-07-28 | ||
| $138.00/100kg |
VIP3Y
|
Hebei Dangtong Import and export Co LTD
|
2023-03-17 | |
| $200.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-11-28 |
United States- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY